The business of health and well-being is one of the most challenging sectors in the world. Government oversight of this already heavily regulated industry is only going to increase. The specter of liability is always looming, while customers—retail, commercial and government—constantly demand better pricing. Ongoing research is uncovering new advances in medicine and treatment every day, while necessitating a strong emphasis on protecting intellectual property. And healthcare providers are being challenged to improve the quality of care they provide to patients.
While these challenges are daunting, they also portend a bright future. Advances in nanotechnology, genetic mapping and medical devices are opening up new opportunities for industry players, while improving peoples' lives around the world. In this whirlwind of market and regulatory pressures, enterprises need a legal partner that understands the industry and can help anticipate the challenges and opportunities of the future.
McMillan's Life Sciences Industry Group serves public and private sector clients in the biotechnology, pharmaceuticals and healthcare industries. We believe in our clients' missions and are committed to helping them deliver them.
Our strategic and legal counsel helps clients meet the industry's challenges head on, while positioning them to profitably bring new innovations to the market. Our counsel is characterized by its thoroughness, foresight and timeliness.